Showing results (201-210 of 253) with videos related to
Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among VeteransMichael S Wolf, Karen A Fitzner, Eowyn F Powell, et al.Cancer Journal (Sudbury, Mass.)|September 26, 2025
Mitigating the Impact of Drug Shortages in Oncology: Lessons Learned From the 2023 Shortages of Carboplatin and CisplatinMaxwell L Izen, June M McKoy, Linda Martin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports projectLisa A Ladewski, Steven M Belknap, Jonathan R Nebeker, et al.Stroke|January 7, 2004
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug AdministrationAnaadriana Zakarija, Nicholas Bandarenko, Dilip K Pandey, et al.International Journal of Cancer|February 11, 2020
End of an era for erythropoiesis-stimulating agents in oncologyMartin W Schoen, Shamia Hoque, Bartlett J Witherspoon, et al.Cancer Journal (Sudbury, Mass.)|September 26, 2025
Cancer Drugs and United States Tariffs: Attention Must Be PaidMaxwell L Izen, June M McKoy, Linda Martin, et al.Blood|October 24, 2007
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline updateJ Douglas Rizzo, Mark R Somerfield, Karen L Hagerty, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2007
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline updateJ Douglas Rizzo, Mark R Somerfield, Karen L Hagerty, et al.Plos One|September 25, 2024
A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseasesCharles L Bennett, Joseph Magagnoli, Krishna Gundabolu, et al.Journal of Oncology Practice|May 16, 2017
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced AnemiaVirginia Noxon, Kevin B Knopf, LeAnn B Norris, et al.Pageof 26